Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics

Alzheimer s & Dementia Translational Research & Clinical Interventions(2024)10.1002/trc2.12498Source: DataRank Database

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2024). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (18)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Anton P. Porsteinsson ORCID,Marwan Sabbagh,David Watson ORCID,Aidan Power,Earvin Liang

Live enrichment

PubMed:39144121 PMC:PMC11322500

National Institute on Aging

Grant: R01‐AG065253

NIA NIH HHS

Grant: R01 AG065253

National Institutes of Health

Grant: 3R01AG065253-04S1

Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study

goldLicense: cc-by-nc-nd

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12498

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12498

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11322500/pdf/TRC2-10-e12498.pdf

Europe_PMChttps://europepmc.org/articles/PMC11322500

Europe_PMChttps://europepmc.org/articles/PMC11322500?pdf=render

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

Apolipoprotein EAlzheimer's diseaseAmyloid betaDisease ModificationAmyloid Beta OligomersAlz‐801Apolipoprotein E Ε4/Ε4 HomozygotesValiltramiprosateAnti‐oligomer AgentsAnti‐aggregation AgentsRC952-954.6GeriatricsNeurology. Diseases of the nervous systemRC346-429Research Article